Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors
出版年份 2018 全文链接
标题
Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors
作者
关键词
-
出版物
Current Oncology Reports
Volume 20, Issue 11, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-09-26
DOI
10.1007/s11912-018-0730-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- BBI608 inhibits cancer stemness and reverses cisplatin resistance in NSCLC
- (2018) Lauren MacDonagh et al. CANCER LETTERS
- Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent
- (2018) Josep M. Piulats et al. CLINICAL CANCER RESEARCH
- Molecular mechanisms of resistance in testicular germ cell tumors – Clinical implications
- (2018) Katarina Kalavska et al. CURRENT CANCER DRUG TARGETS
- IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance
- (2018) Joanna Selfe et al. JOURNAL OF PATHOLOGY
- Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity
- (2017) Judith Schaffrath et al. PLoS One
- Repair shielding of platinum-DNA lesions in testicular germ cell tumors by high-mobility group box protein 4 imparts cisplatin hypersensitivity
- (2017) Samuel G. Awuah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC
- (2017) Lauren MacDonagh et al. Oncotarget
- Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors
- (2016) Aditya Bagrodia et al. JOURNAL OF CLINICAL ONCOLOGY
- Testicular germ cell tumours
- (2016) Ewa Rajpert-De Meyts et al. LANCET
- Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition
- (2016) Safeena Kulsum et al. MOLECULAR CARCINOGENESIS
- Cancer stem cells and chemoresistance: The smartest survives the raid
- (2016) Jihe Zhao PHARMACOLOGY & THERAPEUTICS
- Phase II study of everolimus in refractory testicular germ cell tumors
- (2016) Michal Mego et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Increased multi-drug resistance and reduced apoptosis in osteosarcoma side population cells are crucial factors for tumor recurrence
- (2016) YANG WANG et al. Experimental and Therapeutic Medicine
- Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine
- (2016) Costantine Albany et al. Oncotarget
- Frequent PD-L1 expression in testicular germ cell tumors
- (2015) C D Fankhauser et al. BRITISH JOURNAL OF CANCER
- Differential expression of stem cell-like proteins in normal, hyperplastic and dysplastic oral epithelium
- (2015) Sarah Mohammed Mohammed BARAKAT et al. Journal of Applied Oral Science
- A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
- (2015) Monica Cojoc et al. SEMINARS IN CANCER BIOLOGY
- Cisplatin Induces Cytotoxicity through the Mitogen-Activated Protein Kinase Pathways ana Activating Transcription Factor 3
- (2015) Carly St. Germain et al. NEOPLASIA
- Colon cancer: Cancer stem cells markers, drug resistance and treatment
- (2014) Zuzana Kozovska et al. BIOMEDICINE & PHARMACOTHERAPY
- Presence of Somatic Mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in Cisplatin-Resistant Germ Cell Tumors
- (2014) D. R. Feldman et al. CLINICAL CANCER RESEARCH
- Cisplatin Induces Resistance by Triggering Differentiation of Testicular Embryonal Carcinoma Cells
- (2014) Paolo B. Abada et al. PLoS One
- MicroRNA-34a: a potential therapeutic target in human cancer
- (2014) X J Li et al. Cell Death & Disease
- Cisplatin resistance in germ cell tumours: models and mechanisms
- (2014) C. Jacobsen et al. Andrology
- Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors
- (2013) Mercè Juliachs et al. BMC CANCER
- Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4
- (2013) M. Gutekunst et al. CANCER RESEARCH
- The PDGFRβ–AKT Pathway Contributes to CDDP-Acquired Resistance in Testicular Germ Cell Tumors
- (2013) M. Juliachs et al. CLINICAL CANCER RESEARCH
- Molecular biology of testicular germ cell tumors: Unique features awaiting clinical application
- (2013) Ludmila Boublikova et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- International Variations and Trends in Testicular Cancer Incidence and Mortality
- (2013) Ariana Znaor et al. EUROPEAN UROLOGY
- Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer
- (2013) R. Koster et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Revisiting DNA damage repair, p53-mediated apoptosis and cisplatin sensitivity in germ cell tumors
- (2013) Francesca Cavallo et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Aldehyde dehydrogenasehigh gastric cancer stem cells are resistant to chemotherapy
- (2013) SHIMPEI NISHIKAWA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- PARP expression in germ cell tumours
- (2013) Michal Mego et al. JOURNAL OF CLINICAL PATHOLOGY
- Proteome analysis of the effects of all-trans retinoic acid on human germ cell tumor cell lines
- (2013) Friedemann Honecker et al. Journal of Proteomics
- Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature
- (2013) Martin P. Barr et al. PLoS One
- Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer
- (2012) B Nitzsche et al. BRITISH JOURNAL OF CANCER
- Chemotherapeutic Sensitivity of Testicular Germ Cell Tumors Under Hypoxic Conditions Is Negatively Regulated by SENP1-Controlled Sumoylation of OCT4
- (2012) Y.-C. Wu et al. CANCER RESEARCH
- Pro- and anti-apoptotic effects of p53 in cisplatin-treated human testicular cancer are cell context-dependent
- (2012) Alessandra di Pietro et al. CELL CYCLE
- Understanding cancer stem cell heterogeneity and plasticity
- (2012) Dean G Tang CELL RESEARCH
- Transcription Factors Sp1 and p73 Control the Expression of the Proapoptotic Protein NOXA in the Response of Testicular Embryonal Carcinoma Cells to Cisplatin
- (2012) Lara Grande et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Acute Hypersensitivity of Pluripotent Testicular Cancer-Derived Embryonal Carcinoma to Low-Dose 5-Aza Deoxycytidine Is Associated with Global DNA Damage-Associated p53 Activation, Anti-Pluripotency and DNA Demethylation
- (2012) Bijesh K. Biswal et al. PLoS One
- Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhibition
- (2012) Francesca Cavallo et al. PLoS One
- Drug-resistant breast cancer cell line displays cancer stem cell phenotype and responds sensitively to epigenetic drug SAHA
- (2012) Shan Lu et al. Drug Delivery and Translational Research
- Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study
- (2011) K. Oechsle et al. ANNALS OF ONCOLOGY
- Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: Endpoints for clinical trial design
- (2011) Darren R. Feldman et al. CANCER
- Lessons learned from testicular cancer: Identification of cytoplasmic p21 as an Achilles' heel of cisplatin resistance
- (2011) Roelof Koster et al. CELL CYCLE
- Long-Term Survival After Treatment with Gemcitabine and Oxaliplatin With and Without Paclitaxel Plus Secondary Surgery in Patients with Cisplatin-Refractory and/or Multiply Relapsed Germ Cell Tumors
- (2011) Karin Oechsle et al. EUROPEAN UROLOGY
- Micro-RNA expression in cisplatin resistant germ cell tumor cell lines
- (2011) Matthias Port et al. Molecular Cancer
- Ovarian Cancer Stem Cell-Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2
- (2011) S. Rizzo et al. MOLECULAR CANCER THERAPEUTICS
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Absence of BRAF mutation in pediatric and adolescent germ cell tumors indicate biological differences to adult tumors
- (2011) Neus Masqué-Soler et al. PEDIATRIC BLOOD & CANCER
- p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin
- (2011) Matthias Gutekunst et al. PLoS One
- Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes
- (2011) Ulrike Beyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Disruption of the MDM2–p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway
- (2011) R Koster et al. Cell Death & Disease
- The Association of CCND1 Overexpression and Cisplatin Resistance in Testicular Germ Cell Tumors and Other Cancers
- (2010) Elodie E. Noel et al. AMERICAN JOURNAL OF PATHOLOGY
- Testicular non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) H.- J. Schmoll et al. ANNALS OF ONCOLOGY
- Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours
- (2010) B Nitzsche et al. BRITISH JOURNAL OF CANCER
- p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors
- (2010) Baozong Li et al. CELL CYCLE
- Histological evidence for the existence of germ cell tumor cells showing embryonal carcinoma morphology but lacking OCT4 expression and cisplatin sensitivity
- (2010) Thomas Mueller et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer
- (2010) Roelof Koster et al. JOURNAL OF CLINICAL INVESTIGATION
- Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance
- (2010) Hendrik Wermann et al. JOURNAL OF PATHOLOGY
- The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines
- (2009) Jackie Perry et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
- (2009) M. J. Beyrouthy et al. CANCER RESEARCH
- Sunitinib Inhibits Tumor Growth and Synergizes with Cisplatin in Orthotopic Models of Cisplatin-Sensitive and Cisplatin-Resistant Human Testicular Germ Cell Tumors
- (2009) W. Castillo-Avila et al. CLINICAL CANCER RESEARCH
- Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
- (2009) T. Tanei et al. CLINICAL CANCER RESEARCH
- Therapeutic Potential of Mdm2 Inhibition in Malignant Germ Cell Tumours
- (2009) Sebastian Bauer et al. EUROPEAN UROLOGY
- Microsatellite Instability, Mismatch Repair Deficiency, andBRAFMutation in Treatment-Resistant Germ Cell Tumors
- (2009) Friedemann Honecker et al. JOURNAL OF CLINICAL ONCOLOGY
- ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients’ outcome
- (2009) Ting Li et al. LABORATORY INVESTIGATION
- Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
- (2009) F. Jiang et al. MOLECULAR CANCER RESEARCH
- Treatment of Growing Teratoma Syndrome
- (2009) David J. Vaughn et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started